Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wheless, J. W.
Right arrow Articles by Maggio, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheless, J. W.
Right arrow Articles by Maggio, V.

Neurology 2002;59:S21-S25
© 2002 American Academy of Neurology

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

Vagus nerve stimulation therapy in patients younger than 18 years

James W. Wheless, MD and Vijay Maggio, MD

From the Texas Comprehensive Epilepsy Program, University of Texas–Houston (Dr. Wheless) and University of Texas Medical School, Department of Neurology (Dr. Maggio), Houston, TX.

Address correspondence and reprint requests to Dr. James Wheless, Texas Comprehensive Epilepsy Program, University of Texas–Houston, Medical School, MSB 7.044, 6431 Fannin, Houston, TX 77030.

Article abstract Nonpharmacologic treatment options are effective in reducing seizures and improving quality of life without the negative side effects associated with antiepileptic drug (AED) therapy among pediatric epilepsy patients. One such treatment, vagus nerve stimulation (VNS) therapy, appears to be particularly effective among pediatric patients with refractory seizures. Seizure severity and frequency, as well as quality of life, are improved with VNS therapy.




This article has been cited by other articles:


Home page
 J Child NeurolHome page
E. M. S. Sherman, M. B. Connolly, D. J. Slick, K. L. Eyrl, P. Steinbok, and K. Farrell
Quality of Life and Seizure Outcome After Vagus Nerve Stimulation in Children With Intractable Epilepsy
J Child Neurol, September 1, 2008; 23(9): 991 - 998.
[Abstract] [PDF]

Home page
 J. Physiol.Home page
L. El-Hassar, M. Milh, F. Wendling, N. Ferrand, M. Esclapez, and C. Bernard
Cell domain-dependent changes in the glutamatergic and GABAergic drives during epileptogenesis in the rat CA1 region
J. Physiol., January 1, 2007; 578(1): 193 - 211.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. J. Vecht and M. van Breemen
Optimizing therapy of seizures in patients with brain tumors
Neurology, December 26, 2006; 67(12_suppl_4): S10 - S13.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.